State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, Liaoning Province, China.
Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, 110001, China.
Virol J. 2024 Nov 26;21(1):306. doi: 10.1186/s12985-024-02563-z.
In the evolution landscape of HIV, the coexistence of multiple subtypes has led to new, complex recombinants, posing public health challenges. CRF55_01B, first identified among MSM in Shenzhen, China, has spread rapidly across China. In this study, 47 plasma samples from newly diagnosed HIV-1 CRF55_01B patients in Shenzhen, of which the genotype was only identified by the routine HIV drug resistance test, were collected. Multiple gene regions were acquired using Sanger and next-generation sequencing methods, followed by the phylogenetic reconstruction, recombination breakpoint scanning, Bayesian molecular clock, and the prediction of coreceptors. From 47 samples, we found seven new unique recombinants formed by CRF55_01B and CRF07_BC, which shared similar breakpoints in certain gene regions and primarily utilized CCR5 receptors. All of the most recent common ancestors of subregions for these recombinants were estimated to be later than CRF55_01B and CRF07_BC, potentially suggesting they are the third-generation recombinants formed by CRF55_01B and CRF07_BC as parents. The continuous emergence of new recombinants highlights the increasing complexity of circulating strains in Shenzhen, and also suggests that subtype analysis using partial pol gene may lead to an overestimation of the major subtype strains and an underestimation of new complex HIV recombinants. Consequently, to effectively address and mitigate the complex HIV epidemic, there is an urgent need for expanded monitoring and the optimization of testing methodologies.
在 HIV 的进化格局中,多种亚型的共存导致了新的、复杂的重组体的出现,给公共卫生带来了挑战。CRF55_01B 最初在中国深圳的男男性行为者(MSM)中被发现,现已迅速在中国传播。在这项研究中,共收集了来自深圳新诊断的 HIV-1 CRF55_01B 患者的 47 份血浆样本,这些患者的基因型仅通过常规 HIV 耐药性检测确定。使用 Sanger 和下一代测序方法获得了多个基因区域,随后进行了系统发育重建、重组断点扫描、贝叶斯分子钟和核心受体预测。从 47 个样本中,我们发现了 7 种由 CRF55_01B 和 CRF07_BC 形成的新独特重组体,它们在某些基因区域具有相似的断点,主要利用 CCR5 受体。这些重组体的子区域的所有最近共同祖先都被估计晚于 CRF55_01B 和 CRF07_BC,这可能表明它们是由 CRF55_01B 和 CRF07_BC 作为亲本形成的第三代重组体。新重组体的不断出现突显了深圳流行株的复杂性不断增加,这也表明使用部分 pol 基因进行亚型分析可能会导致对主要亚型株的高估和对新的复杂 HIV 重组体的低估。因此,为了有效应对和缓解复杂的 HIV 流行,迫切需要扩大监测范围并优化检测方法。